Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
Stock data | 2024 | Change |
---|---|---|
Price | $2.08 | N/A |
Market Cap | $1.00B | N/A |
Shares Outstanding | 479.68M | N/A |
Employees | 0 | N/A |